The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.18
Ask: 0.20
Change: -0.01 (-5.00%)
Spread: 0.02 (11.111%)
Open: 0.20
High: 0.00
Low: 0.00
Prev. Close: 0.20
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

1 Jul 2020 11:15

RNS Number : 7234R
Nuformix PLC
01 July 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Nuformix PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

David Joszef Tapolczay

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

22/06/2020

6. Date on which issuer notified (DD/MM/YYYY):

30/06/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.90%

6.90%

490,145,083

Position of previous notification (if

applicable)

7.97%

7.97%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYW79Y38

33,850,000

6.90%

SUBTOTAL 8. A

33,850,000

6.90%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

David Joszef Tapolczay

6.90%

6.90%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information

 

Place of completion

Hertfordshire, UK

Date of completion

22nd June 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLKKDBDKBKDNOK
Date   Source Headline
10th Mar 20217:00 amRNSProposed Placing to raise £1.565 million
8th Mar 202112:00 pmRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResearch Results
22nd Feb 20213:45 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:01 pmRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSAppointment of Broker
22nd Dec 20207:00 amRNSHalf-year Report
7th Dec 20207:00 amRNSAppointment of Chief Executive Officer
2nd Dec 20207:00 amRNSAppointment of Non-Executive Director
24th Nov 20207:00 amRNSAppointment of Non-Executive Director
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
26th Oct 20202:16 pmRNSHolding(s) in Company
22nd Oct 20205:45 pmRNSHolding(s) in Company
22nd Oct 20204:16 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSPlacing and Strategic Update
24th Sep 20207:00 amRNSExclusive Option Agreement for NXP001
20th Aug 202011:33 amRNSResult of AGM
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:36 pmRNSPrice Monitoring Extension
19th Aug 20202:24 pmRNSResults Pre-clinical Pilot Study in IPF for NXP004
28th Jul 202012:14 pmRNSAnnual Report and Notice of AGM 2020
22nd Jul 20207:00 amRNSPreliminary Results for year ended 31 March 2020
1st Jul 202011:15 amRNSNotification of Major Holdings
22nd Jun 20207:00 amRNSBoard Change
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSBusiness Update
27th May 20207:00 amRNSNuformix and VistaGen Announce CNS Agreement
6th May 20203:30 pmRNSHolding(s) in Company
3rd Apr 20203:31 pmRNSHolding(s) in Company
30th Mar 20203:42 pmRNSNotiication of Major Share Holding
9th Mar 20204:42 pmRNSSecond Price Monitoring Extn
9th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSAppointment of Dr Karl Keegan
14th Feb 20204:41 pmRNSSecond Price Monitoring Extn
14th Feb 20204:35 pmRNSPrice Monitoring Extension
14th Feb 20202:05 pmRNSSecond Price Monitoring Extn
14th Feb 20202:00 pmRNSPrice Monitoring Extension
13th Feb 20204:40 pmRNSSecond Price Monitoring Extn
13th Feb 20204:35 pmRNSPrice Monitoring Extension
12th Feb 20204:10 pmRNSNotification of Major Holdings
5th Feb 20205:05 pmRNSOperational Update
5th Feb 20204:45 pmRNSResignation of Dave Tapolczay
5th Feb 20202:24 pmRNSDirector Dealing
5th Feb 20202:19 pmRNSNotification of Major Holdings
27th Jan 20207:00 amRNSResignation of John Lidgey
27th Jan 20207:00 amRNSMajor Shareholding Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.